MEDICENTRAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDICENTRAL
Largest movements
- Receivables within one year +€93,575
up €93,575 (+53.4%), from €175,225 to €268,800
of which Other amounts receivable: +€107,618
- Cash -€8,941
down €8,941 (-67.1%), from €13,316 to €4,375
mainly Receivables within one year (-€93,575) and Trade debts (-€3,890)
- Profit (loss) carried forward +€64,789
up €64,789 (+47.3%), from €137,015 to €201,804
- Tax, wage and social debts +€23,585
up €23,585 (+95.1%), from €24,805 to €48,390
- Trade debts -€3,890
down €3,890 (-58.0%), from €6,711 to €2,821
- Gross operating margin -€2,367
down €2,367 (-2.8%), from €83,430 to €81,063
- Taxes -€1,220
down €1,220 (-4.9%), from €24,805 to €23,585
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €188,991 | €273,475 | +€84,484 | +44.7% |
| Fixed assets | 21/28 | €300 | €300 | = | 0.0% |
| Financial fixed assets | 28 | €300 | €300 | = | 0.0% |
| Current assets | 29/58 | €188,691 | €273,175 | +€84,484 | +44.8% |
| Amounts receivable within one year | 40/41 | €175,225 | €268,800 | +€93,575 | +53.4% |
| Trade receivables | 40 | €20,611 | €6,568 | -€14,043 | -68.1% |
| Other amounts receivable | 41 | €154,614 | €262,232 | +€107,618 | +69.6% |
| Cash at bank and in hand | 54/58 | €13,316 | €4,375 | -€8,941 | -67.1% |
| Deferred charges and accrued income | 490/1 | €150 | €0 | -€150 | -100% |
| Total equity and liabilities | 10/49 | €188,991 | €273,475 | +€84,484 | +44.7% |
| Equity | 10/15 | €157,475 | €222,264 | +€64,789 | +41.1% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €137,015 | €201,804 | +€64,789 | +47.3% |
| Amounts payable | 17/49 | €31,516 | €51,211 | +€19,695 | +62.5% |
| Amounts payable within one year | 42/48 | €31,516 | €51,211 | +€19,695 | +62.5% |
| Trade debts | 44 | €6,711 | €2,821 | -€3,890 | -58.0% |
| Suppliers | 440/4 | €6,711 | €2,821 | -€3,890 | -58.0% |
| Taxes, remuneration and social security | 45 | €24,805 | €48,390 | +€23,585 | +95.1% |
| Taxes | 450/3 | €24,805 | €48,390 | +€23,585 | +95.1% |
| Other operating charges | 640/8 | €387 | €400 | +€12 | +3.2% |
| Gross operating margin | 9900 | €83,430 | €81,063 | -€2,367 | -2.8% |
| Operating profit (loss) | 9901 | €83,043 | €80,663 | -€2,380 | -2.9% |
| Financial income | 75/76B | €7,558 | €7,747 | +€189 | +2.5% |
| Recurring financial income | 75 | €7,558 | €7,747 | +€189 | +2.5% |
| Financial charges | 65/66B | €40 | €36 | -€4 | -10.2% |
| Recurring financial charges | 65 | €40 | €36 | -€4 | -10.2% |
| Profit (loss) for the period before taxes | 9903 | €90,561 | €88,374 | -€2,186 | -2.4% |
| Income taxes | 67/77 | €24,805 | €23,585 | -€1,220 | -4.9% |
| Profit (loss) for the period | 9904 | €65,755 | €64,789 | -€966 | -1.5% |
| Profit (loss) for the period to be appropriated | 9905 | €65,755 | €64,789 | -€966 | -1.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 21 October 2026 via checked.be.